Get started
BIONANO GENOMICS, INCBIONANO GENOMICS, INCBIONANO GENOMICS, INC

BIONANO GENOMICS, INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

BNGO chart


Full chart

BNGO upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪276.42 M‬ MXN
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1,915.15 MXN
Net income (FY)
‪−2.34 B‬ MXN
Revenue (FY)
‪641.66 M‬ MXN
Shares float
‪3.00 M‬
Beta (1Y)
2.16

Employees


Employees (FY)
100
Change (1Y)
−244 −70.93%
Revenue / Employee (1Y)
‪6.42 M‬ MXN
Net income / Employee (1Y)
‪−23.35 M‬ MXN

About Bionano Genomics, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Robert Erik Holmlin
Website
bionano.com
Headquarters
San Diego
Founded
2003
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

BNGO news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as BNGO.

Frequently Asked Questions


The current price of BNGO is 87.83 MXN — it has increased by 41.39% in the past 24 hours. Watch BIONANO GENOMICS, INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange BIONANO GENOMICS, INC stocks are traded under the ticker BNGO.
BNGO stock has risen by 30.89% compared to the previous week, the month change is a −8.13% fall, over the last year BIONANO GENOMICS, INC has showed a 412.13% increase.
We've gathered analysts' opinions on BIONANO GENOMICS, INC future price: according to them, BNGO price has a max estimate of 208.68 MXN and a min estimate of 83.47 MXN. Watch BNGO chart and read a more detailed BIONANO GENOMICS, INC stock forecast: see what analysts think of BIONANO GENOMICS, INC and suggest that you do with its stocks.
BNGO stock is 32.24% volatile and has beta coefficient of 2.16. Track BIONANO GENOMICS, INC stock price on the chart and check out the list of the most volatile stocks — is BIONANO GENOMICS, INC there?
Today BIONANO GENOMICS, INC has the market capitalization of ‪291.51 M‬, it has decreased by −3.16% over the last week.
Yes, you can track BIONANO GENOMICS, INC financials in yearly and quarterly reports right on TradingView.
BIONANO GENOMICS, INC is going to release the next earnings report on May 7, 2025. Keep track of upcoming events with our Earnings Calendar.
BNGO earnings for the last quarter are −254.78 MXN per share, whereas the estimation was −122.97 MXN resulting in a −107.19% surprise. The estimated earnings for the next quarter are −61.94 MXN per share. See more details about BIONANO GENOMICS, INC earnings.
BIONANO GENOMICS, INC revenue for the last quarter amounts to ‪170.19 M‬ MXN, despite the estimated figure of ‪125.10 M‬ MXN. In the next quarter, revenue is expected to reach ‪128.04 M‬ MXN.
BNGO net income for the last quarter is ‪−419.59 M‬ MXN, while the quarter before that showed ‪−871.81 M‬ MXN of net income which accounts for 51.87% change. Track more BIONANO GENOMICS, INC financial stats to get the full picture.
No, BNGO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 15, 2025, the company has 100 employees. See our rating of the largest employees — is BIONANO GENOMICS, INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIONANO GENOMICS, INC EBITDA is ‪−1.50 B‬ MXN, and current EBITDA margin is −232.28%. See more stats in BIONANO GENOMICS, INC financial statements.
Like other stocks, BNGO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIONANO GENOMICS, INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIONANO GENOMICS, INC technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIONANO GENOMICS, INC stock shows the buy signal. See more of BIONANO GENOMICS, INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.